The economic burden of depression in the US: societal and patient perspectives

Author： Greenberg Paul E   Birnbaum Howard G  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.3, 2005-03, pp. : 369-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measuring the Patient Health, Societal and Economic Benefits of US Pediatric Therapeutics Legislation

By Vernon John A.   Shortenhaus Scott H.  

Pediatric Drugs, Vol. 14, Iss. 5, 2012-10 ,pp. : 283-294

Adis International

Access to resources Recommend Favorite

Societal and Patient Burden of Fibromyalgia Syndrome

By Annemans Lieven  

PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. : 547-559

Adis International

Access to resources Recommend Favorite

Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment

By Donohue Julie M.   Harold Alan Pincus  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 7-24

Adis International

Access to resources Recommend Favorite

Economic burden of osteoarthritis in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Economic burden of psoriasis in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite